Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shahin Isha, MBBS"'
Publikováno v:
Mayo Clinic Proceedings: Digital Health, Vol 1, Iss 3, Pp 352-356 (2023)
Externí odkaz:
https://doaj.org/article/07fc9c77c0824be888e0acb817ace0fe
Autor:
Patrick W. Johnson, BS, Katie L. Kunze, PhD, Jonathon W. Senefeld, PhD, Jorge E. Sinclair, MD, Shahin Isha, MBBS, Parthkumar H. Satashia, MBBS, Shivang Bhakta, MD, Jennifer B. Cowart, MD, Wendelyn Bosch, MD, Jack O’Horo, MD, Sadia Z. Shah, MD, Hani M. Wadei, MD, Michael A. Edwards, MD, Benjamin D. Pollock, PhD, Alana J. Edwards, Sidna Scheitel-Tulledge, MD, Caroline G. Clune, MD, Sara N. Hanson, DO, Richard Arndt, PharmD, Alexander Heyliger, PharmD, Cory Kudrna, MBA, Dennis M. Bierle, MD, Jason R. Buckmeier, BS, Maria Teresa A. Seville, MD, Robert Orenstein, DO, Claudia Libertin, MD, Ravindra Ganesh, MD, Pablo Moreno Franco, MD, Raymund R. Razonable, MD, Rickey E. Carter, PhD, Devang K. Sanghavi, MD, Leigh L. Speicher, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 7, Iss 2, Pp 109-121 (2023)
Objective: To test the hypothesis that the Monoclonal Antibody Screening Score performs consistently better in identifying the need for monoclonal antibody infusion throughout each “wave” of severe acute respiratory syndrome coronavirus 2 (SARS-C
Externí odkaz:
https://doaj.org/article/d8c852a606ff46b89e15c5a2c422bc09
Autor:
Sadia Z. Shah, MD, MBA, Francisco G. Alvarez, MD, Devang K. Sanghavi, MD, Pablo Moreno Franco, MD, Shahin Isha, MBBS, Christopher P. Marquez, MD, Claudia Libertin, MD, Pramod K. Guru, MBBS, MD, Basar Sareyyupoglu, MD, Si M. Pham, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 7, Iss 2, Pp 93-98 (2023)
Coronavirus disease 2019 (COVID-19) pandemic has led to considerable morbidity and mortality across the world. Lung transplant is a viable option for a few with COVID-19–related lung disease. Whom and when to transplant has been the major question
Externí odkaz:
https://doaj.org/article/f8354396b7e5470b82b446de1d2ccb07
Autor:
Melissa P. Cortes, MD, Carrie S. Schultz, PA-C, MS, Shahin Isha, MBBS, Jorge E. Sinclair, MD, Shivang Bhakta, MD, Katie L. Kunze, PhD, MA, Patrick W. Johnson, BS, Jennifer B. Cowart, MD, Rickey E. Carter, PhD, Pablo Moreno Franco, MD, Devang K. Sanghavi, MBBS, MD, Archana Roy, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 6, Iss 5, Pp 409-419 (2022)
Objective: To assess the proportion of indeterminate QuantiFERON-TB Gold Plus (QFT-Plus) results in patients admitted for severe coronavirus disease 2019 (COVID-19) pneumonia and evaluate the factors associated with indeterminate QFT-Plus results. Pa
Externí odkaz:
https://doaj.org/article/1e00cd0cad5a422badf6c9eeee6f0cc8